Industry leaders weigh in on drug evaluation
Growing drug plan costs are putting pressure on benefits plan sponsors to move to managed formularies—but industry stakeholders must first work together to change the…
- By: Karen Welds
- July 4, 2012 September 13, 2019
- 13:01